Table 3.
Participant experiences of COVID-19 testing and infection
| Variable | Refugee (%) (n = 501) | Citizen (%) (n = 491) | Chi–square (DF) | P–value |
|---|---|---|---|---|
| Underwent a COVID–19 test | ||||
| No | 223 (64.1) | 125 (35.9) | 39.53 (1) | < 0.001* |
| Yes | 278 (43.2) | 366 (56.8) | ||
| Type of the healthcare facility | ||||
| Governmental or NGOs (free) | 254 (48.7) | 268 (51.3) | 33.87 (1) | < 0.001* |
| Private (paid) | 24 (19.7) | 98 (80.3) | ||
| Tested positive for COVID–19 | ||||
| No | 410 (59.5) | 279 (40.5) | 73.13 (1) | < 0.001* |
| Yes | 91 (30.0) | 212 (70.0) | ||
| The severity of COVID–19 infection | ||||
| No symptoms | 12 (54.5) | 10 (45.5) | 9.87 (3) | 0.020* |
| Mild | 18 (24.7) | 55 (75.3) | ||
| Moderate | 30 (25.0) | 90 (75.0) | ||
| Severe | 31 (35.2) | 57 (64.8) | ||
| The serial interval of COVID–19 symptoms | ||||
| 1–2 days | 6 (18.2) | 27 (81.8) | 7.14 (3) | 0.068 |
| 3–4 days | 21 (25.0) | 63 (75.0) | ||
| 5–7 days | 17 (24.6) | 52 (75.4) | ||
| 8 days and above | 37 (38.1) | 60 (61.9) | ||
| Taking antibiotics to treat COVID–19 | ||||
| No | 29 (23.6) | 94 (76.4) | 2.71 (1) | 0.100 |
| Yes | 52 (32.5) | 108 (67.5) | ||
DF Degrees of freedom
*Statistically significant